![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-adgif-27965.gif)
![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-ad-w33-mob-headergif-39012.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.globenewswire.com/news-release/2024/03/27/2853003/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Levofloxacin-Oral-Solution-USP.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://health.economictimes.indiatimes.com/news/pharma/chinas-covid-surge-corona-drug-associated-apis-get-costlier/96509567
https://www.pharmatimes.com/news/santen_launches_ducressa_for_post-cataract_surgery_1453357
https://www.prnewswire.com/news-releases/ntc-und-aspen-geben-positives-sahpra-ergebnis-fur-die-fest-dosierte-kombination-aus-levofloxacin-und-dexamethason-augentropfen-in-mehreren-dosen-bekannt-809733682.html
https://www.news-medical.net/news/20200713/7-day-levofloxacindexamethasone-eye-drops-as-effective-as-standard-treatment-after-cataract-surgery.aspx
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205540
https://www.pharmacompass.com/pdf/news/auromedics-pharma-issues-voluntary-nationwide-recall-of-levofloxacin-in-5-dextrose-250mg50ml-1587013407.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/antibiotic-resistance-in-food-animals-growing/articleshow/71213015.cms
https://www.prnewswire.com/news-releases/ntc-grants-further-license-and-distribution-rights-to-santen-for-its-fixed-combination-dexamethasone-with-levofloxacin-in-south-east-asia-300853181.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204968
https://www.nbcnews.com/health/health-news/fda-warns-some-antibiotics-can-cause-serious-heart-damage-n950606
https://www.raps.org/news-and-articles/news-articles/2018/12/aorta-tears-with-certain-antibiotic-use-fda-warns?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20December
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-3-2018-1538550050.pdf
https://health.economictimes.indiatimes.com/news/pharma/commonly-used-antibiotic-in-india-under-usfda-lens/64958016
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/73954
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-9-2018-1525842214.pdf
https://www.pharmacompass.com/pdf/news/auromedics-pharma-llc-issues-voluntary-nationwide-recall-of-levofloxacin-in-5-dextrose-250mg50ml-1516242254.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204899
http://ir.horizon-pharma.com/news-releases/news-release-details/horizon-pharma-plc-completes-sale-european-marketing-rights
http://www.business-standard.com/article/companies/cadila-healthcare-moraiya-plant-receives-eir-from-usfda-117062100598_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205968
http://www.business-standard.com/article/markets/cadila-healthcare-hits-record-high-on-usfda-approval-for-levofloxacin-117060200244_1.html
http://www.biospectrumasia.com/news/26/8985/taigen-biotechnology-announces-the-submission-of-nda-for-taigexyn-to-the-cfda.html
http://www.nasdaq.com/press-release/horizon-pharma-plc-announces-agreement-to-sell-european-marketing-rights-to-procysbi-cysteamine-20170523-01193
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-5-2017-1491371454.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2017-1489584258.pdf
https://www.pharmacompass.com/pdf/news/approved-new-list-of-candidate-drugs-to-bioisencao-1475582007.pdf
http://www.prnewswire.com/news-releases/hillary-clintons-medical-condition-may-be-result-of-her-taking-dangerous-drug-levaquin-according-to-larry-klayman-300328917.html
http://www.fiercepharma.com/pharma/a-new-wave-levaquin-lawsuits-patients-claim-j-j-knew-about-nerve-damage-risks
http://www.forbes.com/sites/judystone/2016/02/18/common-antibiotics-may-cause-confusion-and-hallucinations/?ss=pharma-healthcare#35e36a5f4a1b
http://www.indiainfoline.com/article/news-top-story/aurobindo-pharma-gets-fda-nod-bacterial-infection-injection-dextrose-116021100243_1.html?
http://www.biospace.com/News/ex-fda-head-accused-of-conspiring-to-suppress/408195/source=TopBreaking
http://www.pharma-excipients.ch/2016/02/03/development-and-evaluation-of-floating-microparticles-for-levofloxacin-as-a-gastroretentive-carrier/
http://www.fiercepharma.com/story/levaquin-users-slap-jj-800m-rico-suit-claiming-pharma-giant-hid-serious-sid/2016-01-21
http://www.prnewswire.com/news-releases/larry-klayman-files-lawsuit-against-former-fda-commissioner-hamburg-johnson--johnson-and-others-sued-for-alleged-racketeering-and-other-claims-over-dangerous-drug-levaquin-300206300.html
http://www.prnewswire.com/news-releases/taigens-intravenous-taigexynr-successfully-achieved-primary-endpoint-in-phase-3-clinical-trial-for-community-acquired-pneumonia-300187520.html
http://www.reuters.com/article/2015/09/08/us-tetraphase-study-idUSKCN0R82JJ20150908
https://www.pharmacompass.com/pdf/news/hospiras-generic-levofloxacin-in-dextrose-5-approved-in-us-for-infections-1441626027.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203613Orig1s000ltr.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0358-2015&w=01282015&lang=eng
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002239.jsp&mid=WC0b01ac058004d5c1
http://www.pharmabiz.com/NewsDetails.aspx?aid=85642&sid=2